Long-term fate of left atrial thrombi and incidence of cerebral embolism under continuous anticoagulation therapy;MR-tomographische evaluation der inzidenz zerebraler embolien bei patienten mit vorhofflimmern und linksatrialen thromben

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 177, Issue 12, 2005, Pages 1706-1712

  Strach, K ^a   Meyer, C ^a   Hackenbroch, M ^a   Tiemann, K ^a   Haase, J ^b   Pizulli, L ^c   Omran, H ^d   Schild, H ^a   Sommer, T ^a,e  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Klinik Rotes Kreuz   (Germany)

^c Petruskrankenhaus   (Germany)

^d ST MARIEN HOSPITAL   (Germany)

^e St Marien Hospital ^*  (Germany)

Author keywords

Atrial fibrillation; Atrial thrombi; Cerebral embolism; Cerebral infarction; Diffusion weighted imaging; MR imaging

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; PHENPROCOUMON;

ACUTE DISEASE; ADULT; AGED; ANTICOAGULATION; APPARATUS; ARTICLE; BRAIN EMBOLISM; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; EVALUATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART LEFT ATRIUM; HIGH RISK POPULATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 29144536835     PISSN: 14389029     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858787     Document Type: Article

References (32)

1. Ferro JM. Atrial fibrillation and cardioembolic stroke. Minerva Cardioangiol 2004; 52: 111-124
2. Hart RG, Halperin JL, Pearce LA et al. Lessons from stroke prevention in atrial fibrillation trials. Ann Intern Med 2003; 138: 831-838
3. Wolf PA, Abbott RD, Kannel WB et al. Atrial fibrillation as an indipendent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988
4. Gonzalez RG, Schaefer PW, Buonanno et al. Diffusion-weighted MR imaging: diagnostic accuracy in patients imaged within 6 hours of stroke symptom onset. Radiology 1999; 210: 155-162
5. Fuster V, Ryden LE, Singer RW et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences. Eur Heart J 2001; 22: 1852-1923
6. Laupacis A, Albers G, Dalen J et al. Antithrombotic therapy in atrial fibrillation. Chest 1995; 108: 352-359
7. Hylek EM, Go AS, Chang Y et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349: 1019-1026
8. Go AD, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. Jama 2001; 285: 2370-2375
9. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469-473
10. Mattle HP, Schwerzmann M, Seiler C. Vorhofflimmern und Hirninfarkt. Ther Umsch 2003; 60: 527- 534
11. Benjamin EJ, Wolf PA, D'Agostino RB et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-952
12. Fiehler JT, Kucinski T, Zeumer H. Das Schlaganfall-MRT: Pathophysiologie, Potenzial und Perspektiven. Fortschr Röntgenstr 2004; 176: 313-323
13. Moseley ME, Kucharczyk J, Mintorovitch J et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 1990; 11: 423-429
14. Warach S, Gaa J, Siewert B et al. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol 1995; 37: 231-241
15. Sartor K, Hartmann M, Fiebach J et al. Normale und pathologische Wasserdiffusion im Gehirn. Fortschr Röntgenstr 2003; 175: 1317-1329
16. Kucharczyk J, Vexler ZS, Roberts TP et al. Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia. Radiology 1993; 188: 711-717
17. Chien D, Kwong KK, Gress DR et al. MR diffusion imaging of cerebral infarction in humans. AJNR Am J Neuroradiol 1992; 13: 1097-1102
18. Mintorovitch J, Yang GY, Shimizu H et al. Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: comparison of signal intensity with changes in brain water and Na+, K(+)-ATPase activity. J Cereb Blood Flow Metab 1994; 14: 332-336
19. Matsumo K, Lo EH, Pierce AR et al. Role of vasogenic edema and tissue cavitation in ischemic evolution on diffusion-weighted imaging: comparison with multiparameter MR and immunohistochemistry. AJNR Am J Neuroradiol 1995; 16: 1107-1115
20. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000; 217: 331-345
21. Wick M, Nagatomo Y, Prielmeier F et al. Alteration of intracellular metabolite diffusion in rat brain in vivo during ischemia and reperfusion. Stroke 1995; 26: 1930-1933
22. Duong TQ, Ackerman JJ, Ying HS et al. Evaluation of extra- and intracellular apparent diffusion in normal and globally ischemic rat brain via 19F NMR. Magn Reson Med 1998; 40: 1-13
23. Marks MP, de Crespigny A, Lentz D et al. Acute and chronic stroke: navigated spin-echo diffusion-weighted MR imaging. Radiology 1996; 199: 403-408
24. Geijer B, Lindgren A, Brockstedt S et al. Persistent high signal on diffusion-weighted MRI in the late stages of small cortical and lacunar ischaemic lesions. Neuroradiology 2001; 43: 115-122
25. Romero JM, Schaefer PW, Grant PE et al. Diffusion MR imaging of acute ischemic stroke. Neuroimaging Clin N Am 2002; 12: 35-53
26. Heiland S, Sartor K. Magnetresonanztomographie beim Schlaganfall - Methodische Grundlagen und klinische Anwendung. Fortschr Röntgenstr 1999; 171: 3-14
27. Stollberger C, Chnupa P, Abzieher C et al. Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study. Clin Cardiol 2004; 27: 40-46
28. Bernhardt P, Schmidt H, Hammerstingl C et al. Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging. Am J Cardiol 2004; 94: 801-804
29. Hohnloser SH, Kuck KH, Lilienthal J. Rhythm or rate control in atrial fibrillation -Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial. Lancet 2000; 356: 1789-1794
30. Van Gelder IC, Hagens VE, Bosker HA et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347: 1834-1840
31. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1825-1833
32. Artang R, Vidaillet H. Alternatives to warfarin for thromboembolism prophylaxis in nonrheumatic atrial fibrillation. J Interv Card Electrophysiol 2004; 10: 33-44